Subcutaneous Interferon Beta-1a 22/44 mg Demonstrates Comparable Effectiveness Versus Teriflunomide in Newly Treated Patients with Multiple Sclerosis. a Study in a French Nationwide Cohort of Multiple Sclerosis: Observatoire Francais De La Sclérose En Pla

Fabien Rollot, Caroline Foch, David Laplaud, Emmanuelle Boutmy, Kurt Marhardt, Meritxell Sabidó